Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 67: 959-962, 1989;
8750-7587/89 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emery, D. L.
Right arrow Articles by Nadel, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emery, D. L.
Right arrow Articles by Nadel, J. A.

Journal of Applied Physiology, Vol 67, Issue 3 959-962, Copyright © 1989 by American Physiological Society


ARTICLES

Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea

D. L. Emery, T. D. Djokic, P. D. Graf and J. A. Nadel
Cardiovascular Research Institute, University of California, San Francisco 94143-0130.

Prostaglandin D2 (PGD2), the major product of arachidonic acid metabolism via the cyclooxygenase pathway in most mast cells, is present in the airways of atopic asthmatic patients after antigen challenge. Because eosinophilia is characteristic of asthma, we asked whether PGD2 causes eosinophils to accumulate in the airways in vivo. Using an endotracheal tube with two inflatable balloons we isolated a segment of trachea in four anesthetized mechanically ventilated dogs, and we superfused this segment with either a control solution (Hanks' balanced salt solution and antibiotics) or solution containing PGD2 (10(-6) M). Total and differential cell counts were determined at base line and every hour for 4 h during the study. PGD2 caused eosinophil accumulation in the trachea [7.0 +/- 3.4, 28.7 +/- 17.8, 33.7 +/- 13.6, and 35.4 +/- 10.7 (SD) cells/cm2 trachea after 1, 2, 3, and 4 h, respectively, P less than 0.05 vs. controls] but had no significant effect on neutrophil accumulation. The effect of PGD2 on eosinophil accumulation was significantly inhibited by the prostaglandin receptor antagonist SKF 88046 (5 mg/kg iv). We conclude that PGD2 is a selective stimulus that causes accumulation of eosinophils in the tracheal lumen of dogs in vivo.


This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Shiraishi, K. Asano, K. Niimi, K. Fukunaga, M. Wakaki, J. Kagyo, T. Takihara, S. Ueda, T. Nakajima, T. Oguma, et al.
Cyclooxygenase-2/Prostaglandin D2/CRTH2 Pathway Mediates Double-Stranded RNA-Induced Enhancement of Allergic Airway Inflammation
J. Immunol., January 1, 2008; 180(1): 541 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Sandig, J. E. Pease, and I. Sabroe
Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function
J. Leukoc. Biol., February 1, 2007; 81(2): 372 - 382.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. G. Trivedi, J. Newson, R. Rajakariar, T. S. Jacques, R. Hannon, Y. Kanaoka, N. Eguchi, P. Colville-Nash, and D. W. Gilroy
Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity
PNAS, March 28, 2006; 103(13): 5179 - 5184.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Almishri, C. Cossette, J. Rokach, J. G. Martin, Q. Hamid, and W. S. Powell
Effects of Prostaglandin D2, 15-Deoxy-{Delta}12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 64 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Spik, C. Brenuchon, V. Angeli, D. Staumont, S. Fleury, M. Capron, F. Trottein, and D. Dombrowicz
Activation of the Prostaglandin D2 Receptor DP2/CRTH2 Increases Allergic Inflammation in Mouse
J. Immunol., March 15, 2005; 174(6): 3703 - 3708.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Shiraishi, K. Asano, T. Nakajima, T. Oguma, Y. Suzuki, T. Shiomi, K. Sayama, K. Niimi, M. Wakaki, J. Kagyo, et al.
Prostaglandin D2-Induced Eosinophilic Airway Inflammation Is Mediated by CRTH2 Receptor
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 954 - 960.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. Honda, M. Arima, G. Cheng, S. Taki, H. Hirata, F. Eda, F. Fukushima, B. Yamaguchi, M. Hatano, T. Tokuhisa, et al.
Prostaglandin D2 Reinforces Th2 Type Inflammatory Responses of Airways to Low-dose Antigen through Bronchial Expression of Macrophage-derived Chemokine
J. Exp. Med., August 18, 2003; 198(4): 533 - 543.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. N. Hata, R. Zent, M. D. Breyer, and R. M. Breyer
Expression and Molecular Pharmacology of the Mouse CRTH2 Receptor
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 463 - 470.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Li, Y. Yang, and R. L. Stevens
RasGRP4 Regulates the Expression of Prostaglandin D2 in Human and Rat Mast Cell Lines
J. Biol. Chem., February 7, 2003; 278(7): 4725 - 4729.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. T. Borchers, P. J. Justice, T. Ansay, V. Mancino, M. P. McGarry, J. Crosby, M. I. Simon, N. A. Lee, and J. J. Lee
Gq Signaling Is Required for Allergen-Induced Pulmonary Eosinophilia
J. Immunol., April 1, 2002; 168(7): 3543 - 3549.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Fujitani, Y. Kanaoka, K. Aritake, N. Uodome, K. Okazaki-Hatake, and Y. Urade
Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice
J. Immunol., January 1, 2002; 168(1): 443 - 449.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Monneret, S. Gravel, M. Diamond, J. Rokach, and W. S. Powell
Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
Blood, September 15, 2001; 98(6): 1942 - 1948.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Arimura, K. Yasui, J. Kishino, F. Asanuma, H. Hasegawa, S. Kakudo, M. Ohtani, and H. Arita
Prevention of Allergic Inflammation by a Novel Prostaglandin Receptor Antagonist, S-5751
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 411 - 419.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Hirai, K. Tanaka, O. Yoshie, K. Ogawa, K. Kenmotsu, Y. Takamori, M. Ichimasa, K. Sugamura, M. Nakamura, S. Takano, et al.
Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor CRTH2
J. Exp. Med., January 16, 2001; 193(2): 255 - 262.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. Matsuoka, M. Hirata, H. Tanaka, Y. Takahashi, T. Murata, K. Kabashima, Y. Sugimoto, T. Kobayashi, F. Ushikubi, Y. Aze, et al.
Prostaglandin D2 as a Mediator of Allergic Asthma
Science, March 17, 2000; 287(5460): 2013 - 2017.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
M. A. Giembycz and M. A. Lindsay
Pharmacology of the Eosinophil
Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online